ALM · Almonty Industries Inc.

Current Thesis

Almonty Industries' non-China tungsten production thesis has failed its published price test; Sangdong's next quarterly results must establish whether the operating case survives. The 2026-09-18 weekly close of $13.84 breached the $15.50 invalidation published on 2026-09-06. That is an observed failure of the prior price structure, not evidence that the mine has stopped operating.

The substantive development since the previous note is the 2026-09-14 binding Rwanda partnership. Almonty announced a 75% interest in the venture, with Rwanda receiving 25% for an exploration concession and processing licence. The agreement contemplates sourcing material from existing licensed producers; it does not establish realized revenue from that activity. Company announcement

For the previously published price-supported advance, the narrative is dead — the 2026-09-18 close broke its stated threshold despite the Rwanda announcement. This is an inference about that narrative leg. A weekly recovery above $15.50 accompanied by stronger reported operating earnings would challenge the assessment.

Bullish and bearish views on Almonty Industries Inc.

The model's bull view on Almonty Industries Inc. (ALM), in brief: Operating earnings provide a benchmark. The 2026-08-11 second-quarter release reported revenue of C$43.0 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of C$17.6 million. These establish the operating comparison for the next results.… The bear view: The published threshold has failed. The adjusted market close was $13.84 on 2026-09-18, below the $15.50 weekly threshold in the 2026-09-06 research note. Retaining that threshold records the failure without substituting an unsupported lower level. Revenue already missed… Both cases follow in full.

Bull Case

• Operating earnings provide a benchmark. The 2026-08-11 second-quarter release reported revenue of C$43.0 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of C$17.6 million. These establish the operating comparison for the next results. Company results
• Contract terms support the production case. The same release disclosed that the 2026-07-14 Global Tungsten & Powders amendment extended the agreement by six years, increased contracted volumes by 40% and improved pricing by approximately 6.3%. Those are contractual changes; realized revenue still depends on deliveries. Company results
• Rwanda broadens the sourcing route. The 2026-09-14 agreement provides for acquiring ore, pre-concentrate and tailings from licensed producers, with exports contemplated before construction of a permanent processing plant. Actual shipment and revenue disclosures would establish whether this additional route contributes commercially. Company announcement

Bear Case

• The published threshold has failed. The adjusted market close was $13.84 on 2026-09-18, below the $15.50 weekly threshold in the 2026-09-06 research note. Retaining that threshold records the failure without substituting an unsupported lower level.
• Revenue already missed expectations. Benzinga's 2026-08-11 earnings report recorded second-quarter sales of US$31.053 million against US$35.038 million expected. A further miss accompanied by adjusted EBITDA no higher than the reported second-quarter C$17.6 million would undermine the operating expansion case.
• Commodity pricing had softened. The China Tungsten Industry Association's 2026-08-31 review placed European ammonium paratungstate (APT) at US$2,900–3,000 per metric tonne unit, below the company's second-quarter average of US$3,075 per metric tonne unit. September's comparable average is missing, so continued deterioration cannot be asserted.

Setup & Price Structure

The supplied adjusted daily series records a 2026-09-18 close of $13.84, a three-month decline of 25.8%, and a price 40.9% below the trailing 52-week high of $23.42. The 14-period relative strength index was 26.7 on that date. These measurements describe weakness; they do not establish a reversal or a new support shelf.

Analyst support persisted during the decline: D.A. Davidson maintained its US$33 price target on 2026-09-15, according to Benzinga's analyst-action record. That is an observable research opinion, not evidence of purchases or expanding participation. Benzinga analyst record

No dated moving-average series, short-interest figure or fund-flow series is available in the evidence reviewed. Analyst coverage and the 2026-09-18 price decline therefore cannot establish how crowded ownership is.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Third-quarter accounting cutoff. The quarter closes after Sangdong's company-announced 2026-07-01 start of processing operations. This is an accounting milestone, not a scheduled results release; it defines the period for assessing the production contribution. Company processing announcement
• ~2026-11-12, est. Third-quarter results. This remains the unconfirmed estimate carried in the 2026-09-06 public note, outside the next 30 days. The relevant comparisons are revenue against contemporaneous expectations and adjusted EBITDA against the C$17.6 million reported on 2026-08-11. No company-confirmed release date was identified.

No company-confirmed earnings, shipment or commissioning announcement date was identified for the next 30 days as of 2026-09-20.

What Would Change Our Mind

The lost post-authorization price structure is the decisive change: a weekly close below $15.50 was the published thesis-break condition, and the 2026-09-18 close of $13.84 satisfied it. The earlier case is invalidated.

A renewed production-led case would require both a weekly close above the former $15.50 threshold and quarterly evidence of stronger operations: revenue meeting contemporaneous consensus and adjusted EBITDA exceeding the second-quarter C$17.6 million reported on 2026-08-11. A subsequent weekly close below $15.50 would invalidate that recovery interpretation; another revenue miss with no EBITDA expansion would reject its operating premise.

Correlation Notes

This remains a single-name assessment. The 2026-08-11 results and the 2026-08-31 European APT quotation identify tungsten pricing as an operating exposure, but the available observations are too few to support a measured equity-price correlation.

Benzinga's 2026-09-10 market report described falling Nasdaq prices alongside higher oil prices and Treasury yields. Without matched daily returns for Almonty and those markets, that episode cannot establish whether macro conditions explain the company's decline.